Results 251 to 260 of about 5,411,820 (260)

The pathology of primary progressive multiple sclerosis

Multiple Sclerosis Journal, 2002
Hans Lassmann, C Lucchinetti
exaly  

In vivo evidence of oxidative stress in brains of patients with progressive multiple sclerosis

Multiple Sclerosis Journal, 2018
Peter Adany, In-Young Choi, Phil Lee
exaly  

Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial

Lancet, The, 2016
Fred D. Lublin, Catherine Lubetzki, Bruce A C Cree   +2 more
exaly  

Imaging outcome measures for progressive multiple sclerosis trials

Multiple Sclerosis Journal, 2017
Antonio Giorgio, Marcello Moccia, Frederik Barkhof   +2 more
exaly  

Gene expression analysis of relapsing–remitting, primary progressive and secondary progressive multiple sclerosis

Multiple Sclerosis Journal, 2013
Per Soelberg Sørensen, H B Søndergaard, Ps Sørensen   +2 more
exaly  

CSF inflammatory biomarkers responsive to treatment in progressive multiple sclerosis capture residual inflammation associated with axonal damage

Multiple Sclerosis Journal, 2019
Finn Sellebjerg, Jeppe Romme Christensen, Rikke Ratzer   +2 more
exaly  

Intensive Immunosuppression in Progressive Multiple Sclerosis — A Randomized, Three-Arm Study of High-Dose Intravenous Cyclophosphamide, Plasma Exchange, and ACTH

New England Journal of Medicine, 1983
Stephen L. Hauser, Howard L. Weiner, John A Mills   +2 more
exaly  

Progressive multiple sclerosis: prospects for disease therapy, repair, and restoration of function

Lancet, The, 2017
Jeffrey A Cohen, Daniel Ontaneda, Robert J. Fox   +2 more
exaly  

Anti-BCMA CAR-T therapy in patients with progressive multiple sclerosis

Cell

exaly  

Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis

New England Journal of Medicine
Daniel S. Reich, Robert J. Fox, Sana Syed   +2 more
exaly